Investor Relations

Corporate Overview

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, proudly based in San Diego. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia.

Latest Financial Results

FY 2023

Fiscal Year Ended Dec 31, 2023

News Icon

Latest News

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

Events Icon

Recent Event

CLARITY Phase 3 Topline Results Conference Call

IR Contacts


LENZ Therapeutics, Inc.
445 Marine View Ave.
Suite 320
Del Mar, CA 92014
T: 858-925-7000

Investor Relations

Stern Investor Relations, Inc.
Julie Seidel
T: 212-698-8684

Transfer Agent

Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449

Connect With Us